|
Volumn 54, Issue 3, 2001, Pages 215-217
|
Clinical features of diabetic patients with 0.01-0.1% heteroplasmy A3243G mutation in leukocyte mitochondrial DNA [2]
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ENZYME;
GLUTAMATE DECARBOXYLASE;
HEMOGLOBIN A1C;
INSULIN;
LACTIC ACID;
MITOCHONDRIAL DNA;
SULFONYLUREA;
ADULT;
AGED;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEUROPATHY;
DIET THERAPY;
DISEASE ASSOCIATION;
FEMALE;
GLUCOSE BLOOD LEVEL;
HEARING LOSS;
HUMAN;
HYPERGLYCEMIA;
INSULIN RELEASE;
LACTATE BLOOD LEVEL;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MUSCLE TISSUE;
MUSCLE WEAKNESS;
MUTATION;
ONSET AGE;
OXIDATIVE STRESS;
PATHOGENESIS;
POLYMERASE CHAIN REACTION;
SCREENING TEST;
ADULT;
AGE FACTORS;
AGE OF ONSET;
AGED;
DIABETES MELLITUS;
DNA, MITOCHONDRIAL;
FEMALE;
HUMANS;
LEUKOCYTES;
MALE;
MIDDLE AGED;
MUTATION;
|
EID: 0034748245
PISSN: 01688227
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-8227(01)00295-9 Document Type: Letter |
Times cited : (5)
|
References (8)
|